Terms: = Ovarian cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
87 results:
1. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating pi3k/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
2. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
3. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract] [Full Text] [Related]
4. m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis.
Tian Q; Mu Q; Liu S; Huang K; Tang Y; Zhang P; Zhao J; Shu C
Carcinogenesis; 2023 Dec; 44(12):859-870. PubMed ID: 37738681
[TBL] [Abstract] [Full Text] [Related]
5. Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives.
Zhou WC; Zhang QF; Chen JL; Gan JP; Li YK; Zou J
Clin Exp Med; 2023 Dec; 23(8):4449-4456. PubMed ID: 37659993
[TBL] [Abstract] [Full Text] [Related]
6. Pan-cancer Analysis Reveals cancer-dependent Expression of SOX17 and Associated Clinical Outcomes.
Xu LI; Bai Y; Cheng Y; Sheng X; Sun D
Cancer Genomics Proteomics; 2023; 20(5):433-447. PubMed ID: 37643784
[TBL] [Abstract] [Full Text] [Related]
7. CXCL8 and the peritoneal metastasis of ovarian and gastric cancer.
Fu X; Wang Q; Du H; Hao H
Front Immunol; 2023; 14():1159061. PubMed ID: 37377954
[TBL] [Abstract] [Full Text] [Related]
8. pi3k/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells.
Navaei ZN; Khalili-Tanha G; Zangouei AS; Abbaszadegan MR; Moghbeli M
Oncol Res; 2021; 29(4):235-250. PubMed ID: 37303943
[TBL] [Abstract] [Full Text] [Related]
9. Histological and Genetic Diversity in ovarian Mucinous Carcinomas: A Pilot Study.
Razia S; Nakayama K; Yamashita H; Ishibashi T; Ishikawa M; Kanno K; Sato S; Kyo S
Curr Oncol; 2023 Apr; 30(4):4052-4059. PubMed ID: 37185420
[TBL] [Abstract] [Full Text] [Related]
10. Emerging roles of long non-coding RNA FTX in human disorders.
Sheykhi-Sabzehpoush M; Ghasemian M; Khojasteh Pour F; Mighani M; Moghanibashi M; Mohammad Jafari R; Zabel M; Dzięgiel P; Farzaneh M; Kempisty B
Clin Transl Oncol; 2023 Oct; 25(10):2812-2831. PubMed ID: 37095425
[TBL] [Abstract] [Full Text] [Related]
11. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-induced miR-9 expression promotes ovarian cancer progression via activating pi3k/AKT/mTOR/GSK3β signaling pathway.
Zhu WJ; Huang HH; Feng YF; Zhan L; Yang J; Zhu L; Wang QY; Wei B; Wang WY
Neoplasma; 2023 Apr; 70(2):216-228. PubMed ID: 36964721
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of CLDN16 in ovarian cancer is modulated by pi3k and PKC pathways.
Paes MF; Zipinotti Dos Santos D; Massariol Pimenta T; Ribeiro Junior RS; da Silva Martins B; Greco SJ; Carvalho AA; Bacchi C; Duarte C; Carvalho Í; Silva IV; Azevedo Rangel LB
Exp Cell Res; 2023 May; 426(2):113523. PubMed ID: 36889572
[TBL] [Abstract] [Full Text] [Related]
14. Novel therapeutics in low-grade serous ovarian cancer.
Cobb L; Gershenson D
Int J Gynecol Cancer; 2023 Mar; 33(3):377-384. PubMed ID: 36878564
[TBL] [Abstract] [Full Text] [Related]
15. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
Dundr P; Bártů M; Bosse T; Bui QH; Cibula D; Drozenová J; Fabian P; Fadare O; Hausnerová J; Hojný J; Hájková N; Jakša R; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Šafanda A; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; Stružinská I; McCluggage WG
Mod Pathol; 2023 Jan; 36(1):100040. PubMed ID: 36788074
[TBL] [Abstract] [Full Text] [Related]
16. Advances in ovarian cancer Treatment Beyond PARP Inhibitors.
Aliyuda F; Moschetta M; Ghose A; Sofia Rallis K; Sheriff M; Sanchez E; Rassy E; Boussios S
Curr Cancer Drug Targets; 2023; 23(6):433-446. PubMed ID: 36757037
[TBL] [Abstract] [Full Text] [Related]
17. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
18. Clinical analysis and literature review of a case of ovarian clear cell carcinoma with pik3ca gene mutation: A case report.
Farah AM; Gu S; Jia Y
Medicine (Baltimore); 2022 Sep; 101(37):e30666. PubMed ID: 36123851
[TBL] [Abstract] [Full Text] [Related]
19. UBE2T regulates epithelial-mesenchymal transition through the pi3k-AKT pathway and plays a carcinogenic role in ovarian cancer.
Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X
J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429
[TBL] [Abstract] [Full Text] [Related]
20. The Value of the Stemness Index in ovarian cancer Prognosis.
Yuan H; Yu Q; Pang J; Chen Y; Sheng M; Tang W
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741755
[TBL] [Abstract] [Full Text] [Related]
[Next]
